Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Simon T Schäfer"'
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0197637 (2018)
BACKGROUND:Sepsis is now operationally defined as life-threatening organ dysfunction caused by an infection, identified by an acute change in SOFA-Score of at least two points, including clinical chemistry such as creatinine or bilirubin concentratio
Externí odkaz:
https://doaj.org/article/e118a48e1d9646129e8b04b8d044ca7e
Autor:
Simon T Schäfer, Sophia Gessner, André Scherag, Katharina Rump, Ulrich H Frey, Winfried Siffert, Astrid M Westendorf, Jörg Steinmann, Jürgen Peters, Michael Adamzik
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e104953 (2014)
BACKGROUND:Previous investigations and meta-analyses on the effect of glucocorticoids on mortality in septic shock revealed mixed results. This heterogeneity might be evoked by genetic variations. Such candidate is a promoter polymorphism (-94ins/del
Externí odkaz:
https://doaj.org/article/7eab1cf054f94afc931c248e79a86408
Publikováno v:
Thrombosis Journal, Vol 20, Iss 1, Pp 1-9 (2022)
Abstract Background The detection of direct oral anticoagulants (DOACs) is still challenging but important in emergency patients. We recently demonstrated that modified thromboelastometry can detect rivaroxaban and dabigatran. Data on the detection r
Externí odkaz:
https://doaj.org/article/1c5a4927474748179bdea16de4cb851f
Autor:
Simon T. Schäfer, Anne-Christine Otto, Alice-Christin Acevedo, Klaus Görlinger, Steffen Massberg, Tobias Kammerer, Philipp Groene
Publikováno v:
Thrombosis Journal, Vol 19, Iss 1, Pp 1-11 (2021)
Abstract Background DOAC detection is challenging in emergency situations. Here, we demonstrated recently, that modified thromboelastometric tests can reliably detect and differentiate dabigatran and rivaroxaban. However, whether all DOACs can be det
Externí odkaz:
https://doaj.org/article/f3a451000dba48f8be53e9001b9dcd02
Autor:
Linda E. Cox, Kai Walstein, Lena Völlger, Friederike Reuner, Alexandra Bick, Annika Dötsch, Andrea Engler, Jürgen Peters, Maren von Köckritz-Blickwede, Simon T. Schäfer
Publikováno v:
BMC Anesthesiology, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background There is little knowledge, whether in patients with sepsis neutrophil extracellular trap (NET) formation and NET degrading nuclease activity are altered. Thus, we tested the hypotheses that 1) NET formation from neutrophils of sep
Externí odkaz:
https://doaj.org/article/a9e95e84342c4822aab23297fcb152e2
Autor:
Sarah Thaler, Dana Stöhr, Tobias Kammerer, Tobias Nitschke, Dominik J. Hoechter, Florian Brandes, Martin Müller, Philipp Groene, Simon T. Schäfer
Publikováno v:
Acta Clinica Belgica. :1-9
Autor:
Philipp Groene, Steffen Massberg, Tobias Kammerer, Alice-Christin Acevedo, Anne-Christine Otto, Klaus Görlinger, Simon T. Schäfer
Publikováno v:
Thrombosis Journal, Vol 19, Iss 1, Pp 1-11 (2021)
Thrombosis Journal
Thrombosis Journal
Background DOAC detection is challenging in emergency situations. Here, we demonstrated recently, that modified thromboelastometric tests can reliably detect and differentiate dabigatran and rivaroxaban. However, whether all DOACs can be detected and
Autor:
Susana da Silva Gaspar Jung, Philipp Groene, Alice-Christin Acevedo, Barbara Lenhart, Simon T. Schäfer
Publikováno v:
Thrombosis Research. 199:75-78
Autor:
Thomas Saller, Tobias Kammerer, Simon T. Schäfer, Sophia R. Sappel, Paula A. Sa, Sven Peterss, Patrick Scheiermann, Andreas Giebl, Christian Hagl, Philipp Groene
Publikováno v:
Transfus Med Hemother
Introduction: Tranexamic acid (TXA) is the standard medication to prevent or treat hyperfibrinolysis. However, prolonged inhibition of lysis (so-called “fibrinolytic shutdown”) correlates with increased mortality. A new viscoelastometric test ena
Autor:
Daniel Chappell, Tobias Nitschke, Alexander C. Paulus, Paula A. Sa, Simon T. Schäfer, Sophia R. Sappel, Philipp Groene, Thomas Saller
Publikováno v:
Journal of Thrombosis and Thrombolysis. 51:989-996
Tranexamic acid (TXA) can reduce blood loss and transfusion rates in orthopaedic surgery. In this regard, a new viscoelastometric test (TPA-test, ClotPro), enables the monitoring of TXA effects. This prospective observational study evaluated and corr